Bowel Urgency and Abdominal Pain in Patients With Moderately to Severely Active Ulcerative Colitis in the Etrasimod ELEVATE UC Clinical Program: A Post Hoc Analysis

被引：0
|
作者：
Dubinsky, Marla C. [1 ]
Chaparro, Maria [2 ]
Armuzzi, Alessandro [3 ]
Irving, Peter M. [4 ,6 ]
Allez, Matthieu [5 ]
Panaccione, Remo [6 ]
Goetsch, Martina [7 ]
Bartolome, Lauren [8 ]
Bananis, Eustratios [9 ]
Wu, Joseph [10 ]
Wosik, Karolina [11 ]
Bhattacharjee, Abhishek [12 ]
Smith, Christina C. [9 ]
Sands, Bruce E. [13 ]
机构：
[1] Mt Sinai Kravis Childrens Hosp, New York, NY USA
[2] Univ Autonoma Madrid UAM, Inst Invest Sanitaria Princesa IIS Princesa, Hosp Univ La Princesa, Ctr Invest Biomed Red Hepat & Digest, Madrid, Spain
[3] IRCCS Humanitas Res Hosp, Milan, Italy
[4] Guys & St Thomas Natl Hlth Serv Fdn Trust, London, England
[5] Univ Paris Cite, Hop St Louis, Paris, Ile De France, France
[6] Univ Calgary, Calgary, AB, Canada
[7] Pfizer AG, Zurich, Switzerland
[8] Pfizer Inc, New York, NY USA
[9] Pfizer Inc, Collegeville, PA USA
[10] Pfizer Inc, Cambridge, MA USA
[11] Pfizer Canada, Kirkland, PQ, Canada
[12] Pfizer Healthcare India Pvt Ltd, Chennai, Tamil Nadu, India
[13] Icahn Sch Med Mt Sinai, New York, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1164
引用
收藏
页码：S889 / S890
页数：2
相关论文
共 50 条
  • [41] COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY: EXPERIENCE OF BOWEL URGENCY FOR PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS
    Hibi, Toshifumi
    Panaccione, Remo
    Bleakman, Alison Potts
    Kayhan, Cem
    Ellis, Hilary
    Gibble, Theresa H.
    Shan, Mingyang
    Atkinson, Christian
    Rubin, David T.
    GASTROENTEROLOGY, 2022, 162 (07) : S444 - S444
  • [42] CHARACTERIZATION OF PLASMA INFLAMMATORY PROTEIN ABUNDANCE IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH ETRASIMOD: AN EXPLORATORY ANALYSIS OF THE PHASE 3 ELEVATE UC 52 AND ELEVATE UC 12 TRIALS
    Siegmund, Britta
    Ryan, Rathi D.
    Abreu, Maria T.
    Vermeire, Severine
    Dotan, Iris
    Goetsch, Martina
    Crosby, Catherine
    Woolcott, John
    Komori, H. Kiyomi
    Danese, Silvio
    GASTROENTEROLOGY, 2023, 164 (06) : S659 - S659
  • [43] Patient perception of bowel urgency and remission in moderately to severely active Crohn's disease or ulcerative colitis: a qualitative study
    Gibble, Theresa Hunter
    Stassek, Larissa
    Harding, Gale
    Stefan, Marissa
    Fikre, Tsion
    Bleakman, Alison Potts
    Moses, Richard
    Dubinsky, Marla
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2024, 8 (01)
  • [44] Non-serious adverse events in patients with ulcerative colitis receiving etrasimod: An analysis of the phase 2 OASIS and phase 3 ELEVATE UC 52 and ELEVATE UC 12 clinical trials
    Lees, C.
    Torres, J.
    Leung, Y.
    Vermeire, S.
    Fellmann, M.
    Modesto, I.
    McDonnell, A.
    Lazin, K.
    Keating, M.
    Goetsch, M.
    Wu, J.
    Loftus, E. V., Jr.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1055 - I1057
  • [45] Health-Related Quality of Life Outcomes With Etrasimod Treatment in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From ELEVATE UC 52 and ELEVATE UC 12 (sep, 10.1093/ibd/izae229/7778239, 2024)
    Armuzzi, Alessandro
    Rubin, David T.
    Schreiber, Stefan
    Panes, Julian
    Fellmann, Marc
    Bartolome, Lauren
    Gruben, David
    Goetsch, Martina
    Bhattacharjee, Abhishek
    Chaparro, Maria
    Dubinsky, Marla C.
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [46] Matching-Adjusted Indirect Comparison of Etrasimod Versus Ozanimod for Clinical Response and Remission Among Patients With Moderately to Severely Active Ulcerative Colitis
    Jairath, Vipul
    Leahy, Thomas P.
    Potluri, Ravi
    Wosik, Karolina
    Gruben, David
    Cappelleri, Joseph C.
    Hur, Peter
    Bartolome, Lauren
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1058 - S1059
  • [47] HEALTH-RELATED QUALITY OF LIFE FROM THE INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH ETRASIMOD IN THE PHASE 3 ELEVATE UC 52 AND ELEVATE UC 12 TRIALS
    Armuzzi, Alessandro
    Rubin, David T.
    Schreiber, Stefan
    Panes, Julian
    Fellmann, Marc
    Bartolome, Lauren
    Goetsch, Martina
    Bhattacharjee, Abhishek
    Wu, Joseph
    Chaparro, Maria
    Dubinsky, Marla C.
    GASTROENTEROLOGY, 2023, 164 (06) : S689 - S689
  • [48] Efficacy of Etrasimod in Patients With Ulcerative Colitis: A Post Hoc Analysis Based on Baseline Endoscopic Subscore
    Yarur, Andres J.
    Reinisch, Walter
    Chang, Shannon
    Gecse, Krisztina B.
    Green, Jesse
    Abbatemarco, Arcangelo M.
    Wu, Joseph
    Goetsch, Martina
    Lazin, Krisztina
    Pradeep, Gokul
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1025 - S1026
  • [49] Relationship Between Vedolizumab Concentrations and Deep Remission in Patients With Moderately-to-Severely Active Ulcerative Colitis: A GEMINI 1 Post Hoc Analysis
    William, Sandborn
    Jean-Frederic, Colombel
    Remo, Panaccione
    Parambir, Dulai
    Maria, Rosario
    Charlie, Cao
    Morris, Barocas
    Karen, Lasch
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S2 - S2
  • [50] Health-related quality of life from the Inflammatory Bowel Disease Questionnaire in patients with ulcerative colitis treated with etrasimod in the phase 3 ELEVATE UC 52 and ELEVATE UC 12 trials
    Armuzzi, A.
    Rubin, D. T.
    Schreiber, S.
    Panes, J.
    Fellmann, M.
    Bartolome, L.
    Goetsch, M.
    Bhattacharjee, A.
    Wu, J.
    Chaparro, M.
    Dubinsky, M. C.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 593 - 594
12345